Prostate Cancer in 2024: What's New in Research and Treatment

Join ZERO Prostate Cancer and Dr. Yaw Nyame of the University of Washington to guide us through the key takeaways from the latest American Society of Clinical Oncology Genitourinary (ASCO GU) symposium. This comprehensive discussion will cover the ongoing debate on renaming low-risk prostate cancer, weighing the pros and cons, and we’ll talk about specific screening recommendations for Black men, a demographic disproportionately affected by this disease. Plus, we’ll be unpacking information from the 2024 Facts & Figures from the American Cancer Society, with a special focus on the alarming increase in advanced prostate cancer diagnoses.
For more information, visit zerocancer.org.

[@steveg6978]

How about insurance companies not fighting MRI's like they use to 6 years ago

[@johngrimkowski598]

Steve I paid 1900 out of pocket with my insurance.

[@MediaTerryAllen]

This is an amazing insight- but how can BASPAC scale up to other cities.

[@kamuconkamucon8543]

Is it possible to consider Kenya in the research and program?The need is high here.

[@MediaTerryAllen]

How do i attend the summit?

[@mauricewilliams1130]

Low rate prostate cancer, should we call (can) That it can Develop. into cancer. Maurice